Published in Nutrients on June 28, 2013
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell (2014) 0.91
Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. Cell Metab (2016) 0.77
Explanation of colon cancer pathophysiology through analyzing the disrupted homeostasis of bile acids. Afr Health Sci (2014) 0.77
Iron, inflammation and invasion of cancer cells. Clujul Med (2015) 0.77
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis (2015) 0.77
Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary. Oncol Lett (2015) 0.75
Micronutrients: A double-edged sword in microbial-induced gastric carcinogenesis. Trends Cancer (2015) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature (1987) 10.21
Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (1997) 9.98
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem (2000) 8.52
Balancing acts: molecular control of mammalian iron metabolism. Cell (2004) 7.82
Human nutrition, the gut microbiome and the immune system. Nature (2011) 7.77
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Molecular genetics of colorectal cancer. Annu Rev Pathol (2011) 7.24
The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta (1996) 6.15
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell (2000) 5.31
Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell (2006) 4.84
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45
Integrative analysis of the cancer transcriptome. Nat Genet (2005) 4.44
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer (2008) 4.41
Transcriptome profile of human colorectal adenomas. Mol Cancer Res (2007) 3.82
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet (1999) 3.30
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
Iron homeostasis. Annu Rev Physiol (2007) 3.22
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut (2010) 3.10
Identification of an intestinal heme transporter. Cell (2005) 3.05
Hepcidin and iron homeostasis. Biochim Biophys Acta (2012) 2.96
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Hepcidin and disorders of iron metabolism. Annu Rev Med (2011) 2.67
Iron and colorectal cancer risk: human studies. Nutr Rev (2001) 2.56
Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem (1999) 2.47
Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest (2005) 2.45
Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res (1999) 2.45
Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One (2010) 2.32
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science (1999) 2.17
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res (2002) 2.12
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst (2008) 2.11
Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr (2000) 2.11
The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr (2010) 2.10
Mouse models for the study of colon carcinogenesis. Carcinogenesis (2008) 2.10
Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood (2006) 2.04
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol (2006) 2.01
A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res (2010) 1.98
Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A (2004) 1.97
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Blood (2012) 1.94
Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med (2010) 1.94
The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta (2002) 1.86
A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis (2010) 1.83
Cancer morbidity in ulcerative colitis. Gut (1982) 1.82
Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst (2003) 1.80
Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem (1999) 1.80
Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res (1999) 1.79
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology (2010) 1.76
Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem (1999) 1.72
Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet (1983) 1.66
Why do African Americans get more colon cancer than Native Africans? J Nutr (2007) 1.64
Mechanisms of mammalian iron homeostasis. Biochemistry (2012) 1.51
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer (2010) 1.50
Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest (2009) 1.48
Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila) (2011) 1.43
The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med (2012) 1.40
Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene (2002) 1.39
Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci (2002) 1.34
Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr (2003) 1.34
Heme and chlorophyll intake and risk of colorectal cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev (2006) 1.33
Body iron stores and risk of cancer. Int J Cancer (1994) 1.31
Red meat and colon cancer: should we become vegetarians, or can we make meat safer? Meat Sci (2011) 1.26
Modulation of iron transport proteins in human colorectal carcinogenesis. Gut (2006) 1.23
Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis (2002) 1.23
What is the function of transferrin in plasma? Blood (1951) 1.22
Effect of processed and red meat on endogenous nitrosation and DNA damage. Carcinogenesis (2009) 1.19
A role for iron in Wnt signalling. Oncogene (2007) 1.19
Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol (2001) 1.18
Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood (2011) 1.18
Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res (2012) 1.17
Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol (2008) 1.17
Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr (1999) 1.17
Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab (2005) 1.16
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. Cancer Res (2011) 1.13
Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst (1994) 1.11
The effects of dietary ferric iron and iron deprivation on the bacterial composition of the mouse intestine. Curr Microbiol (2001) 1.11
Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des (2011) 1.09
Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr (2011) 1.08
The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol (2013) 1.06
Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res (2002) 1.06
Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. Cell Rep (2012) 1.05
Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer. Oncogene (2011) 1.04
Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. Carcinogenesis (2000) 1.03
Intestinal absorption of hemoglobin iron-heme cleavage by mucosal heme oxygenase. J Clin Invest (1974) 1.01
Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst (2005) 1.01
The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract (2012) 0.99
Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. Anticancer Res (2010) 0.99
Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice. Cancer Lett (1988) 0.99
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer (2012) 2.06
Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab (2008) 1.67
Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes (2011) 1.56
PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology (2007) 1.56
Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.50
Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol (2009) 1.46
Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology (2011) 1.38
Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther (2010) 1.31
Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice. Circulation (2007) 1.30
Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology (2013) 1.30
Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther (2007) 1.26
Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology (2011) 1.19
Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res (2012) 1.17
Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology (2012) 1.09
Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J Biol Chem (2011) 1.03
Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab (2012) 1.01
Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci (2012) 0.99
Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia. Proc Natl Acad Sci U S A (2013) 0.98
Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis (2012) 0.97
Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4. BMC Genomics (2012) 0.96
Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling. Blood (2012) 0.93
Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol (2011) 0.92
Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes. J Biol Chem (2012) 0.92
Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells. Steroids (2006) 0.91
Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage. Hepatology (2011) 0.90
A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4. Drug Metab Dispos (2008) 0.90
Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis. J Biol Chem (2009) 0.90
PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells. Toxicol Sci (2010) 0.88
The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression. Mol Cell Biol (2012) 0.85
Iron homeostasis in the liver. Compr Physiol (2013) 0.84
Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasis. PLoS One (2013) 0.82
Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis. Mol Cell Biol (2014) 0.79
Hypoxia-inducible factors: a central link between inflammation and cancer. J Clin Invest (2016) 0.78
In vitro organoid culture of primary mouse colon tumors. J Vis Exp (2013) 0.77
Transgenic mouse models for alcohol metabolism, toxicity, and cancer. Adv Exp Med Biol (2015) 0.76
Cholestasis induces reversible accumulation of periplakin in mouse liver. BMC Gastroenterol (2013) 0.75
Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α. Ann Surg (2016) 0.75